PLRX: Pliant Therapeutics, Inc. Expected earnings per share growth for next year

Public company logo of pliantrx.com (PLRX)

Pliant Therapeutics (PLRX) maintains a high reputation for developing treatments against severe fibrosis, saving patients with lung pathologies. The GURU.Markets platform reflects shifting analyst expectations for EPS n+1 growth, where the reliability of molecule deliveries to clinics confirms logistical precision. The value of 1.80 expresses the latest metric level, while the success of clinical trials and US regulatory status minimize the risks of the development portfolio.

Pliant Therapeutics Inc (PLRX): Net earnings per share change forecast for next year from 07/04/2022 to 11/15/2026

Analytical breakdowns and data insights for company Pliant Rx (PLRX)

- share price and consensus valuation forecast:
Fundamental company valuation:PLRX, Pliant Therapeutics Inc
Finished products of Pliant Therapeutics Inc

This metric reflects the sensitivity of market expectations to operational efficiency, aggregating analyst forecasts for future earnings based on the balance of buy-side and sell-side demand. It measures the fundamental maturity of Pliant Therapeutics (PLRX), accounting for international patent protection risks and the complexities of cross-border drug registration. By analyzing the projected net income trajectory, an investor can assess the impact of geopolitical barriers on the company's capitalization.

Analysis of competing companies

VRTX (Vertex) - Earnings growth forecast for next year|Projected earnings per share growth rate for next year ALNY (Alnylam)|Expected earnings per share growth for next year INSM (Insmed)|UTHR (United Therapeutics Corp) - Expected earnings per share trend next year|Net earnings per share growth forecast for next year BioMarin BMRN|BBIO (BridgeBio Pharma Inc) - Net earnings per share change forecast for next year|BGM Group Ltd - Earnings growth forecast for next year|Expected earnings per share trend next year COGT (Cogent Biosciences)|XERS: Earnings growth forecast for next year|Keros Therapeutics Inc (KROS) - Earnings growth forecast for next year|Net earnings per share growth forecast for next year Arcturus Pharma|ETON: Expected earnings per share trend next year|Net earnings per share growth forecast for next year kamada.com (KMDA)|Expected earnings per share growth for next year Fulcrum Therapeutics FULC|Earnings growth forecast for next year ABEO (Abeona Therapeutics, Inc.)|Earnings growth forecast for next year Mereo BioPharma MREO|PLX - Net earnings per share growth forecast for next year|APLT - Earnings growth forecast for next year|RNTX: Earnings growth forecast for next year|Expected net earnings per share growth next year Gelteq Limited Inc (GELS)|Expected earnings per share growth for next year AYTU|Expected net earnings per share growth next year chemomab.com CMMB|Expected earnings per share growth for next year SRXH (SRx Health Solutions Inc)|PLRZ - Expected net earnings per share growth next year|Net earnings per share growth forecast for next year Aeterna Zentaris AEZS|Cyclo Therapeutics, Inc. (CYTH) - Expected net earnings per share growth next year|INZY - Net earnings per share growth forecast for next year|Expected earnings per share trend next year RPHM (Reneo Pharmaceuticals Inc.)|COSCIENS Biopharma Inc. (CSCI) - Net earnings per share growth forecast for next year